Nkarta, Inc.

📍 South San Francisco, United States🗓 Founded 2015👥 167 employees💰 Last funded Feb 2020
Biotechnology Research🌐 nkartatx.com
Website LinkedIn
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Investor activity2015–2020 · investors recorded per year
201512019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Nkarta, Inc.?
Nkarta, Inc. has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Nkarta, Inc. last raise funding?
The most recent investment in Nkarta, Inc. recorded on gritt.io was in February 2020.
When was Nkarta, Inc. founded?
Nkarta, Inc. was founded in 2015.
What industry is Nkarta, Inc. in?
Nkarta, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nkarta, Inc. based?
Nkarta, Inc. is headquartered in South San Francisco, United States.